We validated the expression of proteins of interest (COL12A1, FUBP1, PLEC, SLC4A1, and TKT) using immunohistochemistry (IHC) and further characterized their expression in online ovarian cancer databases. This evidence concerns the gene TKT and ovarian carcinoma.